Study of new drugs for head and neck cancer and other solid tumors
Part of Cancer clinical trials.
This trial tests two new drugs, BL-B01D1 and SI-B003, alone or together, for people with head and neck squamous cell carcinoma that has come back or spread. It may also include other solid tumors. The goal is to see if these drugs can shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 and no older than 75.
- You have been diagnosed with head and neck squamous cell carcinoma (a type of skin/head cancer) that has come back or spread, and you have tried at least one prior treatment that didn't work or caused bad side effects.
- Your overall health is fairly good (able to do light work or be up and about).
- You have at least one tumor that can be measured on scans.
- Your blood counts and organ function (kidney, liver, heart) are within certain safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug combination (BL-B01D1 plus a PD-1 inhibitor) for people with advanced head and neck cancer or other solid tumors that have come back or spread. It aims to see if the treatment can help shrink tumors or slow the disease.
This trial tests a new drug called SIBP-03 for people with head and neck squamous cell carcinoma that has come back or spread. It is for those whose cancer has worsened after prior immunotherapy and platinum chemotherapy, and who have no option for curative local treatment.
This trial tests an experimental drug called BL-B01D1 for people with several types of advanced solid tumors, especially non-small cell lung cancer and breast cancer. It's designed for those whose cancer has continued to grow after standard treatments.
This trial tests a combination of three medicines (SYS6002, JMT101, and Enlonstobart) for people with head and neck cancer that has come back or spread and cannot be removed by surgery or radiation. The goal is to see if this treatment helps shrink tumors or slow the disease.
This study tests a new drug called BL-M24D1 in people with head and neck cancer or other solid tumors that have spread or cannot be surgically removed. The goal is to see if the drug is safe and can help shrink tumors.
This study tests a new drug, BL-B16D1, for people with advanced head and neck cancer or other solid tumors that have not been helped by standard treatments. The goal is to see if the drug is safe and effective.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.